Exploring the Mechanism of CDK4/6 Inhibitors in Cancer Therapy
CDK4/6 inhibitors have emerged as a cornerstone in treating hormone receptor-positive breast cancer, significantly enhancing patient outcomes by halting tumor proliferation. However, resistance to these therapies presents ongoing challenges. Exploring combination treatments and understanding resistance mechanisms are crucial for advancing cancer care and improving survival rates. Delve into the evolving strategies and future directions in […]
3 minute read